SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-005835
Filing Date
2015-01-22
Accepted
2015-01-22 16:58:11
Documents
2
Period of Report
2015-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1550
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4631
  Complete submission text file 0001209191-15-005835.txt   7563
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 1ST ST. #400 CAMBRIDGE MA 02142
Business Address
Duker Jay S. (Reporting) CIK: 0001630864 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 15542544